Ucsf Hiv/Aids Crs

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• HIV4 trials
• Hepatitis B2 trials
• Cytomegalovirus infection1 trial

Phase

• Phase 22 trials
• Phase 32 trials
• Phase 1/21 trial

Status

• Completed4 trials
• Withdrawn1 trial

Lead sponsor

• National Institute of Allergy and Infectious Diseases (NIAID)5 trials

Closed trials

• Withdrawn

  Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

  NCT04046107· Phase 1/2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)

  NCT05099965· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B

  NCT04193189· Phase 3· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1

  NCT03739996· Phase 2· National Institute of Allergy and Infectious Diseases (NIAID)· Source

• Completed

  The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE

  NCT03635788· Phase 3· National Institute of Allergy and Infectious Diseases (NIAID)· Source